Nishida Akira, Hisaoka Kazue, Zensho Hidenobu, Uchitomi Yousuke, Morinobu Shigeru, Yamawaki Shigeto
Int Immunopharmacol. 2002 Nov;2(12):1619-26. doi: 10.1016/s1567-5769(02)00190-x.
This article reviews recent developments in cytokine research that pertain to pharmacological treatment of mood disorders such as antidepressants and lithium. We review the possible involvement of cytokines in mood disorders and their role in the therapeutic effects of antidepressant drugs. Growing evidence suggests that specific cytokines signal the brain to generate neurochemical, neuroimmune, neuroendocrine and behavior changes. An imbalance of cytokines within the central nervous system (CNS), or even systemically, may play a role in the pathophysiology of mood disorders. Modulation of these cytokines by chronic antidepressant treatment may result in restored balance. However, the effect of antidepressants on cytokines is still unclear both in clinical and preclinical research due to limited data. Further research is needed to clarify the involvement of cytokines in mood disorders. Understanding this relationship may lead to rational, therapeutic improvements in antidepressant and mood stabilizing drugs.
本文综述了细胞因子研究的最新进展,这些进展与情绪障碍(如抗抑郁药和锂盐)的药物治疗有关。我们回顾了细胞因子在情绪障碍中的可能作用及其在抗抑郁药物治疗效果中的作用。越来越多的证据表明,特定的细胞因子向大脑发出信号,引发神经化学、神经免疫、神经内分泌和行为变化。中枢神经系统(CNS)内甚至全身的细胞因子失衡可能在情绪障碍的病理生理学中起作用。长期抗抑郁治疗对这些细胞因子的调节可能会恢复平衡。然而,由于数据有限,抗抑郁药对细胞因子的影响在临床和临床前研究中仍不清楚。需要进一步研究以阐明细胞因子在情绪障碍中的作用。了解这种关系可能会在抗抑郁药和情绪稳定剂方面带来合理的治疗改进。